Logout successfull!

CeramTec is committed to selecting and bringing to interested parties relevant articles on bioceramics related topics. The presented authors’ views and opinions are solely those of the authors of these publications. It is the focus and intent of CeraNews that CeramTec presents and comments on the authors’ views and opinions in a specific context. Such comments and editorials therefore solely express CeramTec’s views and opinions and not necessarily those of the quoted authors.

Issue # 32022

Can We Afford NOT to Use New Technologies?

Stefan Kreuzer MD, MSc

Inov8 Orthopedics
Houston, TX, US

The United States' current spend on healthcare equates to 18% of GDP or USD 3.81 trillion and it is predicted rise to 19.7% by 2028 equating to USD 6.2 trillion. The trend is similarly reflected by most other countries and is simply unsustainable. Healthcare costs must be reduced in both the short- and long-term.


In the short-term, I envision a more optimized health delivery system, one where AI and machine learning enable physicians to incorporate the power of large data sets into personalized patient care. We know every patient is unique, and as is eloquently pointed out by Dr. Keller, the importance of intuition in medical decision-making should also not be underestimated. The synergy of this data driven personalized care will ultimately result in the most appropriate treatment plan within the most appropriate timescale.


Optimization also extends to reducing current resource burdens on the healthcare system, such as periprosthetic joint infection. Both the American and Australian registry annual reports 2022 highlight infection as the most common reason for revision in both hip and knee arthroplasties. The challenging diagnosis and treatment mean that any modifiable risk factors, such as metal bearings, should be avoided. Optimized healthcare delivery is a great value proposition which allows us to provide improved and more cost-effective care to more people in the immediate future.


When considering the long-term, we must be aware that the investment needed in technology is required today, not tomorrow. Robotics, navigation, and more durable devices will all assist in the reduction of future costs by reducing the revision burden for arthroplasty patients. The challenge, however, is predicting the long-term benefit in the short-term. Randomized Controlled Trials, as Prof. Stengel also recognizes, are not the be all and end all as ideal predictors for long-term benefits, despite being frequently required by state agencies or healthcare systems for acceptance.


Better methodologies to assess big data are growing quickly in our field and include the evolution of registry data using machine learning algorithms as well as predictive analytics and AI models which can be used to determine the potentials benefits of new technology. It stands to reason that a tool which is more precise, such as robotics or navigation and a bearing surface that reduces not only wear, but the risk of revision for infection and eliminates metal sensitivity should always be the default and not the exception. In this I can only agree with Prof. Trebše, prevention of infection is an absolute priority.


Much of the research in the field of human longevity and lifespan is based on optimization and personalization to improve health and extend life. David Sinclair, author of ‘Lifespan’ hypothesizes that in the next ten years we will have the knowledge of how to extend life significantly. If these hypotheses become a reality a hip replacement would have to be durable enough to potentially last 50 years. While investment in new technology is costly, the current trends in spending are ultimately unsustainable going forward. The question should not be "Can we afford to use these new technologies?", the question should be "Can we afford NOT to use these new technologies?".


As a final note, if the patients were to be objectively presented with all the current evidence of new technologies, it is my belief that most of them would choose to receive a knee replacement performed with robotics, a hip replacement optimized with navigation, and consolidated bearing surfaces that have the potential to last a lifetime, such as ceramic-on-ceramic. So why the hesitant uptake of these technologies? I’ll let you answer that question.


Stefan Kreuzer MD, MSc

Health Economics & Policy

Medical Decision Making: Where Evidence and Intuition Meet

The reality of how to make a good decision is not as simple as considering personal or professional bias and adjusting accordingly. While best patient outcomes are the aim, the decisions of a clinical team behind these outcomes have been influenced by factors beyond their personal education and experiences. Take a deep dive into how the integration of medical evidence and intuition can support better decision making in the clinical environment.

Outcomes Research

Identifying the Best Evidence for Ceramic Performance in THA

Is Evidence-Based Medicine a misunderstood buzzword? Investigating how and why decisions in healthcare are made is a complex issue. Whilst RCTs are used as a main source of evidence for healthcare authorities we need to consider the evidence quality and context. Conclusions utilizing a best evidence synthesis, including joint international registry data indicate CoC and CoP result in lower overall risk of revision, driven by a lower risk of PJI.

Implant Material

Prevention Is Better than Cure: Challenges in the Treatment of PJI

The surgeon’s ability to optimize his arthroplasty patients and avoid some modifiable risks in a primary procedure should not be neglected. With the challenging diagnosis and treatment of PJI, the resource burden on the healthcare system for revision surgery is high as well as being a significant impairment to quality of life for the patient. When considering PJI the comparative risks of metal to ceramic bearings cannot be underestimated.

Download this Issue

Download the full CeraNews Issue 3/2022 as PDF.

Issue 03/2022
2 MB, pdf

Find previous issues in our archive

Go to archive